Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 560

1.

Chemoprevention with enalapril and aspirin in Men1(+/T) knockout mouse model.

Manoharan J, Fendrich V, Di Fazio P, Bollmann C, Roth S, Joos B, Mintziras I, Albers M, Ramaswamy A, Bertolino P, Zhang CX, Slater EP, Bartsch DK, Lopez-Lopez C.

Neuroendocrinology. 2018 Jul 19. doi: 10.1159/000492224. [Epub ahead of print]

PMID:
30025403
2.

Positive reinforcement targeting abstinence in substance misuse (PRAISe): Study protocol for a Cluster RCT & process evaluation of contingency management.

Metrebian N, Weaver T, Pilling S, Hellier J, Byford S, Shearer J, Mitcheson L, Astbury M, Bijral P, Bogdan N, Bowden-Jones O, Day E, Dunn J, Finch E, Forshall S, Glasper A, Morse G, Akhtar S, Bajaria J, Bennett C, Bishop E, Charles V, Davey C, Desai R, Goodfellow C, Haque F, Little N, McKechnie H, Morris J, Mosler F, Mutz J, Pauli R, Poovendran D, Slater E, Strang J.

Contemp Clin Trials. 2018 Jun 13;71:124-132. doi: 10.1016/j.cct.2018.06.008. [Epub ahead of print]

PMID:
29908336
3.

Genetic and pharmacologic abrogation of Snail1 inhibits acinar-to-ductal metaplasia in precursor lesions of pancreatic ductal adenocarcinoma and pancreatic injury.

Fendrich V, Jendryschek F, Beeck S, Albers M, Lauth M, Esni F, Heeger K, Dengler J, Slater EP, Holler JPN, Baier A, Bartsch DK, Waldmann J.

Oncogene. 2018 Apr;37(14):1845-1856. doi: 10.1038/s41388-017-0100-4. Epub 2018 Jan 25.

PMID:
29367759
4.

Preoperative Imaging Overestimates the Tumor Size in Pancreatic Neuroendocrine Neoplasms Associated with Multiple Endocrine Neoplasia Type 1.

Polenta V, Slater EP, Kann PH, Albers MB, Manoharan J, Ramaswamy A, Mahnken AH, Bartsch DK.

World J Surg. 2018 May;42(5):1440-1447. doi: 10.1007/s00268-017-4317-8.

PMID:
29075857
5.

Persistent Heparin-Induced Thrombocytopenia Treated With IVIg.

Azimov MB, Slater ED.

Chest. 2017 Sep;152(3):679-680. doi: 10.1016/j.chest.2017.05.044. No abstract available.

PMID:
28889885
6.

Overexpression of MicroRNA miR-7-5p Is a Potential Biomarker in Neuroendocrine Neoplasms of the Small Intestine.

Heverhagen AE, Legrand N, Wagner V, Fendrich V, Bartsch DK, Slater EP.

Neuroendocrinology. 2018;106(4):312-317. doi: 10.1159/000480121. Epub 2017 Aug 19.

PMID:
28848144
7.

An unexpected finding of hepatic lymphoma after emergent cholecystectomy.

Steen ST, Slater ED, Barbaro CE, Huebner ER.

J Surg Case Rep. 2017 Mar 7;2017(3):rjx051. doi: 10.1093/jscr/rjx051. eCollection 2017 Mar.

8.

Is Routine Screening of Young Asymptomatic MEN1 Patients Necessary?

Manoharan J, Raue F, Lopez CL, Albers MB, Bollmann C, Fendrich V, Slater EP, Bartsch DK.

World J Surg. 2017 Aug;41(8):2026-2032. doi: 10.1007/s00268-017-3992-9.

PMID:
28321559
9.

Limited Value of Ga-68-DOTATOC-PET-CT in Routine Screening of Patients with Multiple Endocrine Neoplasia Type 1.

Albers MB, Librizzi D, Lopez CL, Manoharan J, Apitzsch JC, Slater EP, Bollmann C, Kann PH, Bartsch DK.

World J Surg. 2017 Jun;41(6):1521-1527. doi: 10.1007/s00268-017-3907-9.

PMID:
28138732
10.

Double germline mutations in APC and BRCA2 in an individual with a pancreatic tumor.

Goehringer C, Sutter C, Kloor M, Gebert J, Slater EP, Keller M, Treiber I, Ganschow P, Kadmon M, Moog U.

Fam Cancer. 2017 Apr;16(2):303-309. doi: 10.1007/s10689-016-9952-y.

PMID:
27838800
11.

Refinement of screening for familial pancreatic cancer.

Bartsch DK, Slater EP, Carrato A, Ibrahim IS, Guillen-Ponce C, Vasen HF, Matthäi E, Earl J, Jendryschek FS, Figiel J, Steinkamp M, Ramaswamy A, Vázquez-Sequeiros E, Muñoz-Beltran M, Montans J, Mocci E, Bonsing BA, Wasser M, Klöppel G, Langer P, Fendrich V, Gress TM.

Gut. 2016 Aug;65(8):1314-21. doi: 10.1136/gutjnl-2015-311098. Epub 2016 May 24.

PMID:
27222532
12.

Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers.

Vasen H, Ibrahim I, Ponce CG, Slater EP, Matthäi E, Carrato A, Earl J, Robbers K, van Mil AM, Potjer T, Bonsing BA, de Vos Tot Nederveen Cappel WH, Bergman W, Wasser M, Morreau H, Klöppel G, Schicker C, Steinkamp M, Figiel J, Esposito I, Mocci E, Vazquez-Sequeiros E, Sanjuanbenito A, Muñoz-Beltran M, Montans J, Langer P, Fendrich V, Bartsch DK.

J Clin Oncol. 2016 Jun 10;34(17):2010-9. doi: 10.1200/JCO.2015.64.0730. Epub 2016 Apr 25.

PMID:
27114589
13.

An unusual phenotype of MEN1 syndrome with a SI-NEN associated with a deletion of the MEN1 gene.

Manoharan J, Lopez CL, Hackmann K, Albers MB, Pehl A, Kann PH, Slater EP, Schröck E, Bartsch DK.

Endocrinol Diabetes Metab Case Rep. 2016;2016:160011. doi: 10.1530/EDM-16-0011. Epub 2016 Mar 2.

14.

Autophagy-related cell death by pan-histone deacetylase inhibition in liver cancer.

Di Fazio P, Waldegger P, Jabari S, Lingelbach S, Montalbano R, Ocker M, Slater EP, Bartsch DK, Illig R, Neureiter D, Wissniowski TT.

Oncotarget. 2016 May 17;7(20):28998-9010. doi: 10.18632/oncotarget.8585.

15.

Reciprocal Changes in Phosphoenolpyruvate Carboxykinase and Pyruvate Kinase with Age Are a Determinant of Aging in Caenorhabditis elegans.

Yuan Y, Hakimi P, Kao C, Kao A, Liu R, Janocha A, Boyd-Tressler A, Hang X, Alhoraibi H, Slater E, Xia K, Cao P, Shue Q, Ching TT, Hsu AL, Erzurum SC, Dubyak GR, Berger NA, Hanson RW, Feng Z.

J Biol Chem. 2016 Jan 15;291(3):1307-19. doi: 10.1074/jbc.M115.691766. Epub 2015 Dec 2.

16.

Bronchopulmonary Neuroendocrine Neoplasms and Their Precursor Lesions in Multiple Endocrine Neoplasia Type 1.

Bartsch DK, Albers MB, Lopez CL, Apitzsch JC, Walthers EM, Fink L, Fendrich V, Slater EP, Waldmann J, Anlauf M.

Neuroendocrinology. 2016;103(3-4):240-7. doi: 10.1159/000435921. Epub 2015 Jun 18.

PMID:
26113081
17.

Health in Action Program, Brazil: a Program Impact Pathways (PIP) analysis.

Slater E, Lasco ML, Capelli J, Pen G.

Food Nutr Bull. 2014 Sep;35(3 Suppl):S108-16.

PMID:
25902580
18.

Limited resection of pancreatic cancer in high-risk patients can result in a second primary.

Potjer TP, Bartsch DK, Slater EP, Matthäi E, Bonsing BA, Vasen HF.

Gut. 2015 Aug;64(8):1342-4. doi: 10.1136/gutjnl-2015-309568. Epub 2015 Apr 2. No abstract available.

PMID:
25838549
19.

Frequency and clinical correlates of somatic Ying Yang 1 mutations in sporadic insulinomas.

Lichtenauer UD, Di Dalmazi G, Slater EP, Wieland T, Kuebart A, Schmittfull A, Schwarzmayr T, Diener S, Wiese D, Thasler WE, Reincke M, Meitinger T, Schott M, Fassnacht M, Bartsch DK, Strom TM, Beuschlein F.

J Clin Endocrinol Metab. 2015 May;100(5):E776-82. doi: 10.1210/jc.2015-1100. Epub 2015 Mar 12.

PMID:
25763608
20.

IGF-1 drives chromogranin A secretion via activation of Arf1 in human neuroendocrine tumour cells.

Münzberg C, Höhn K, Krndija D, Maaß U, Bartsch DK, Slater EP, Oswald F, Walther P, Seufferlein T, von Wichert G.

J Cell Mol Med. 2015 May;19(5):948-59. doi: 10.1111/jcmm.12473. Epub 2015 Mar 8.

21.

Higher risk of aggressive pancreatic neuroendocrine tumors in MEN1 patients with MEN1 mutations affecting the CHES1 interacting MENIN domain.

Bartsch DK, Slater EP, Albers M, Knoop R, Chaloupka B, Lopez CL, Fendrich V, Kann PH, Waldmann J.

J Clin Endocrinol Metab. 2014 Nov;99(11):E2387-91. doi: 10.1210/jc.2013-4432. Epub 2014 Sep 11.

PMID:
25210877
22.

MicroRNA-196a and -196b as Potential Biomarkers for the Early Detection of Familial Pancreatic Cancer.

Slater EP, Strauch K, Rospleszcz S, Ramaswamy A, Esposito I, Klöppel G, Matthäi E, Heeger K, Fendrich V, Langer P, Bartsch DK.

Transl Oncol. 2014 Aug;7(4):464-71. doi: 10.1016/j.tranon.2014.05.007. Epub 2014 Jun 21.

23.

The pan-deacetylase inhibitor panobinostat suppresses the expression of oncogenic miRNAs in hepatocellular carcinoma cell lines.

Henrici A, Montalbano R, Neureiter D, Krause M, Stiewe T, Slater EP, Quint K, Ocker M, Di Fazio P.

Mol Carcinog. 2015 Aug;54(8):585-97. doi: 10.1002/mc.22122. Epub 2013 Dec 23.

PMID:
24375802
24.

LCN2 and TIMP1 as Potential Serum Markers for the Early Detection of Familial Pancreatic Cancer.

Slater EP, Fendrich V, Strauch K, Rospleszcz S, Ramaswamy A, Mätthai E, Chaloupka B, Gress TM, Langer P, Bartsch DK.

Transl Oncol. 2013 Apr;6(2):99-103. Epub 2013 Apr 1.

25.

Sorafenib inhibits tumor growth and improves survival in a transgenic mouse model of pancreatic islet cell tumors.

Fendrich V, Maschuw K, Rehm J, Buchholz M, Holler JP, Slater EP, Bartsch DK, Waldmann J.

ScientificWorldJournal. 2012;2012:529151. doi: 10.1100/2012/529151. Epub 2012 Dec 27.

26.

A Web-based communication aid for patients with cancer: the CONNECT Study.

Meropol NJ, Egleston BL, Buzaglo JS, Balshem A, Benson AB 3rd, Cegala DJ, Cohen RB, Collins M, Diefenbach MA, Miller SM, Fleisher L, Millard JL, Ross EA, Schulman KA, Silver A, Slater E, Solarino N, Sulmasy DP, Trinastic J, Weinfurt KP.

Cancer. 2013 Apr 1;119(7):1437-45. doi: 10.1002/cncr.27874. Epub 2013 Jan 18.

27.

Multiple small "imaging" branch-duct type intraductal papillary mucinous neoplasms (IPMNs) in familial pancreatic cancer: indicator for concomitant high grade pancreatic intraepithelial neoplasia?

Bartsch DK, Dietzel K, Bargello M, Matthaei E, Kloeppel G, Esposito I, Heverhagen JT, Gress TM, Slater EP, Langer P.

Fam Cancer. 2013 Mar;12(1):89-96. doi: 10.1007/s10689-012-9582-y.

PMID:
23179793
28.

Variation in precursor lesions of pancreatic cancer among high-risk groups.

Potjer TP, Schot I, Langer P, Heverhagen JT, Wasser MN, Slater EP, Klöppel G, Morreau HM, Bonsing BA, de Vos Tot Nederveen Cappel WH, Bargello M, Gress TM, Vasen HF, Bartsch DK; Leiden Familial Pancreatic Cancer Group; FaPaCa registry.

Clin Cancer Res. 2013 Jan 15;19(2):442-9. doi: 10.1158/1078-0432.CCR-12-2730. Epub 2012 Nov 21.

29.

Cryopreservation of parathyroid tissue after parathyroid surgery for renal hyperparathyroidism: does it really make sense?

Schneider R, Ramaswamy A, Slater EP, Bartsch DK, Schlosser K.

World J Surg. 2012 Nov;36(11):2598-604. doi: 10.1007/s00268-012-1730-x.

PMID:
22851148
30.

Perspectives on humanism in medicine from the 2012 Edward J. III Excellence in Medicine honorees.

Abrams JS, Owen WF Jr, Brenner JC, Donlen J, Leone P, Carson JL, Slater EE.

MD Advis. 2012 Spring;5(2):4-9. No abstract available.

PMID:
22549607
31.

Clinical impact of TP53 alterations in adrenocortical carcinomas.

Waldmann J, Patsalis N, Fendrich V, Langer P, Saeger W, Chaloupka B, Ramaswamy A, Fassnacht M, Bartsch DK, Slater EP.

Langenbecks Arch Surg. 2012 Feb;397(2):209-16. doi: 10.1007/s00423-011-0868-6. Epub 2011 Dec 29.

PMID:
22203015
32.

Initial parathyroid surgery in 606 patients with renal hyperparathyroidism.

Schneider R, Slater EP, Karakas E, Bartsch DK, Schlosser K.

World J Surg. 2012 Feb;36(2):318-26. doi: 10.1007/s00268-011-1392-0.

PMID:
22202993
33.

Assessing compliance with national comprehensive cancer network guidelines for elderly patients with stage III colon cancer: the Fox Chase Cancer Center Partners' initiative.

O'Grady MA, Slater E, Sigurdson ER, Meropol NJ, Weinstein A, Lusch CJ, Sein E, Keeley P, Miller B, Engstrom PF, Cohen SJ.

Clin Colorectal Cancer. 2011 Jun;10(2):113-6. doi: 10.1016/j.clcc.2011.03.007. Epub 2011 Apr 22.

34.
35.

Hedgehog inhibition with cyclopamine represses tumor growth and prolongs survival in a transgenic mouse model of islet cell tumors.

Fendrich V, Rehm J, Waldmann J, Buchholz M, Christofori G, Lauth M, Slater EP, Bartsch DK.

Ann Surg. 2011 Mar;253(3):546-52. doi: 10.1097/SLA.0b013e31820a5bbe.

PMID:
21239987
36.

German national case collection for familial pancreatic cancer (FaPaCa): ten years experience.

Schneider R, Slater EP, Sina M, Habbe N, Fendrich V, Matthäi E, Langer P, Bartsch DK.

Fam Cancer. 2011 Jun;10(2):323-30. doi: 10.1007/s10689-010-9414-x.

PMID:
21207249
37.

Do soft skills predict surgical performance?: a single-center randomized controlled trial evaluating predictors of skill acquisition in virtual reality laparoscopy.

Maschuw K, Schlosser K, Kupietz E, Slater EP, Weyers P, Hassan I.

World J Surg. 2011 Mar;35(3):480-6. doi: 10.1007/s00268-010-0933-2.

PMID:
21190109
38.

Microarray analysis reveals differential expression of benign and malignant pheochromocytoma.

Waldmann J, Fendrich V, Holler J, Buchholz M, Heinmöller E, Langer P, Ramaswamy A, Samans B, Walz MK, Rothmund M, Bartsch DK, Slater EP.

Endocr Relat Cancer. 2010 Jul 28;17(3):743-56. doi: 10.1677/ERC-09-0118. Print 2010 Sep.

39.

PALB2 mutations in European familial pancreatic cancer families.

Slater EP, Langer P, Niemczyk E, Strauch K, Butler J, Habbe N, Neoptolemos JP, Greenhalf W, Bartsch DK.

Clin Genet. 2010 Nov;78(5):490-4. doi: 10.1111/j.1399-0004.2010.01425.x.

PMID:
20412113
40.

Prevalence of BRCA2 and CDKN2a mutations in German familial pancreatic cancer families.

Slater EP, Langer P, Fendrich V, Habbe N, Chaloupka B, Matthäi E, Sina M, Hahn SA, Bartsch DK.

Fam Cancer. 2010 Sep;9(3):335-43. doi: 10.1007/s10689-010-9329-6.

PMID:
20195775
41.

Clinical and genetic analysis of 18 pancreatic carcinoma/melanoma-prone families.

Bartsch DK, Langer P, Habbe N, Matthäi E, Chaloupka B, Sina M, Hahn SA, Slater EP.

Clin Genet. 2010 Apr;77(4):333-41. doi: 10.1111/j.1399-0004.2009.01352.x. Epub 2009 Dec 22.

PMID:
20041885
42.

The angiotensin-I-converting enzyme inhibitor enalapril and aspirin delay progression of pancreatic intraepithelial neoplasia and cancer formation in a genetically engineered mouse model of pancreatic cancer.

Fendrich V, Chen NM, Neef M, Waldmann J, Buchholz M, Feldmann G, Slater EP, Maitra A, Bartsch DK.

Gut. 2010 May;59(5):630-7. doi: 10.1136/gut.2009.188961. Epub 2009 Nov 1.

PMID:
19880966
43.

Five years of prospective screening of high-risk individuals from families with familial pancreatic cancer.

Langer P, Kann PH, Fendrich V, Habbe N, Schneider M, Sina M, Slater EP, Heverhagen JT, Gress TM, Rothmund M, Bartsch DK.

Gut. 2009 Oct;58(10):1410-8. doi: 10.1136/gut.2008.171611. Epub 2009 May 25.

PMID:
19470496
44.

Expression of the transcription factor snail and its target gene twist are associated with malignancy in pheochromocytomas.

Waldmann J, Slater EP, Langer P, Buchholz M, Ramaswamy A, Walz MK, Schmid KW, Feldmann G, Bartsch DK, Fendrich V.

Ann Surg Oncol. 2009 Jul;16(7):1997-2005. doi: 10.1245/s10434-009-0480-y. Epub 2009 May 2.

PMID:
19412634
45.

Mutations and polymorphisms in the SDHB, SDHD, VHL, and RET genes in sporadic and familial pheochromocytomas.

Waldmann J, Langer P, Habbe N, Fendrich V, Ramaswamy A, Rothmund M, Bartsch DK, Slater EP.

Endocrine. 2009 Jun;35(3):347-55. doi: 10.1007/s12020-009-9178-y. Epub 2009 Apr 28.

PMID:
19399650
46.

Screening of patients with multiple endocrine neoplasia type 1 (MEN-1): a critical analysis of its value.

Waldmann J, Fendrich V, Habbe N, Bartsch DK, Slater EP, Kann PH, Rothmund M, Langer P.

World J Surg. 2009 Jun;33(6):1208-18. doi: 10.1007/s00268-009-9983-8.

PMID:
19350320
47.

Sonic hedgehog and pancreatic-duodenal homeobox 1 expression distinguish between duodenal and pancreatic gastrinomas.

Fendrich V, Ramerth R, Waldmann J, Maschuw K, Langer P, Bartsch DK, Slater EP, Ramaswamy A, Rothmund M.

Endocr Relat Cancer. 2009 Jun;16(2):613-22. doi: 10.1677/ERC-08-0204. Epub 2009 Feb 24.

48.

Expression of the zinc-finger transcription factor Snail in adrenocortical carcinoma is associated with decreased survival.

Waldmann J, Feldmann G, Slater EP, Langer P, Buchholz M, Ramaswamy A, Saeger W, Rothmund M, Fendrich V.

Br J Cancer. 2008 Dec 2;99(11):1900-7. doi: 10.1038/sj.bjc.6604755. Epub 2008 Nov 18.

49.

Fast-growing pancreatic neuroendocrine carcinoma in a patient with multiple endocrine neoplasia type 1: a case report.

Waldmann J, Habbe N, Fendrich V, Slater EP, Kann PH, Rothmund M, Langer P.

J Med Case Rep. 2008 Nov 18;2:354. doi: 10.1186/1752-1947-2-354.

50.

Are diabetic patients at a greater risk to develop a vocal fold palsy during thyroid surgery than nondiabetic patients?

Schlosser K, Maschuw K, Hassan I, Karakas E, Sebastian H, Slater EP, Rothmund M, Fernández ED.

Surgery. 2008 Mar;143(3):352-8. doi: 10.1016/j.surg.2007.10.003. Epub 2007 Dec 21.

PMID:
18291256

Supplemental Content

Loading ...
Support Center